Literature DB >> 24729501

Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in central Australia, 2002-2012.

S Hewagama1, S Krishnaswamy1, L King2, J Davis3, R Baird4.   

Abstract

We retrospectively audited hospital occupational exposure events over a 10-year period, in a human T-cell lymphotropic virus type 1 (HTLV-1)-endemic area of Central Australia, and report on 53 individuals exposed to HTLV-1 with no transmissions documented (95% confidence interval, 0%-1.5%). This has important implications for the management of exposures including the role of postexposure prophylaxis.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HTLV-1; needlestick; occupational exposure

Mesh：

Year:  2014        PMID： 24729501      PMCID： PMC4305138          DOI： 10.1093/cid/ciu227

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

1.  Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.

Authors:  A Manns; W J Miley; R J Wilks; O S Morgan; B Hanchard; G Wharfe; B Cranston; E Maloney; S L Welles; W A Blattner; D Waters
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

2.  Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion.

Authors:  M Osame; R Janssen; H Kubota; H Nishitani; A Igata; S Nagataki; M Mori; I Goto; H Shimabukuro; R Khabbaz
Journal:  Ann Neurol       Date:  1990-07       Impact factor: 10.422

3.  Human T-cell lymphotropic virus type 1 infection and tropical spastic paraparesis in Belgian expatriates.

Authors:  P Goubau; H Carton; P Cornet; G Vercauteren; A Van Gompel; H De Vooght; P Piot; J Desmyter
Journal:  J Med Virol       Date:  1992-01       Impact factor: 2.327

4.  Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.

Authors:  R F Khabbaz; I M Onorato; R O Cannon; T M Hartley; B Roberts; B Hosein; J E Kaplan
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

5.  HTLV-I among Northern Territory aborigines.

Authors:  I Bastian; Y Hinuma; R R Doherty
Journal:  Med J Aust       Date:  1993-07-05       Impact factor: 7.738

Review 6.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

7.  Antiviral effect of raltegravir on HTLV-1 carriers.

Authors:  Ana Treviño; Patricia Parra; Tamara Bar-Magen; Carolina Garrido; Carmen de Mendoza; Vincent Soriano
Journal:  J Antimicrob Chemother       Date:  2011-09-29       Impact factor: 5.790

8.  Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.

Authors:  Shawn A Hill; Patricia A Lloyd; Shannon McDonald; Jennifer Wykoff; David Derse
Journal:  J Infect Dis       Date:  2003-07-10       Impact factor: 5.226

9.  Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group.

Authors:  J E Kaplan; R F Khabbaz; E L Murphy; S Hermansen; C Roberts; R Lal; W Heneine; D Wright; L Matijas; R Thomson; D Rudolph; W M Switzer; S Kleinman; M Busch; G B Schreiber
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-06-01

10.  Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.

Authors:  David T Kuhar; David K Henderson; Kimberly A Struble; Walid Heneine; Vasavi Thomas; Laura W Cheever; Ahmed Gomaa; Adelisa L Panlilio
Journal:  Infect Control Hosp Epidemiol       Date:  2013-09       Impact factor: 3.254
View more
  4 in total

Review 1.  Human T-cell leukemia virus-associated malignancy.

Authors:  Amanda R Panfil; Michael P Martinez; Lee Ratner; Patrick L Green
Journal:  Curr Opin Virol       Date:  2016-08-31       Impact factor: 7.090

Review 2.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

3.  A Qualitative Study Exploring Perceptions to the Human T Cell Leukaemia Virus Type 1 in Central Australia: Barriers to Preventing Transmission in a Remote Aboriginal Population.

Authors:  Fiona Fowler; Lloyd Einsiedel
Journal:  Front Med (Lausanne)       Date:  2022-04-29

4.  Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review.

Authors:  Angela Stufano; Hamid Reza Jahantigh; Francesco Cagnazzo; Francesca Centrone; Daniela Loconsole; Maria Chironna; Piero Lovreglio
Journal:  Viruses       Date:  2021-09-02       Impact factor: 5.048
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.